Mylan, Fujifilm win EU okay for copy of AbbVie's Humira

Mylan and Fujifilm Kyowa Kirin Biologics said on Thursday they had won European approval to market a cheaper copy of AbbVie's $18-billion-a-year biologic drug Humira, the world's best-selling prescription medicine.

Source: Reuters: Health - September 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news